Skip to content

Effect of aragwadhadi kwath (kadha in Hindi) in treatment of mild corona virus disease

Efficacy and Safety of aragwadhadi kwath mentioned in bhavprakash jwarachikitsa 1/155 in mild COVID-19 patients: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025796
Enrollment
90
Registered
2020-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J100- Influenza due to other identifiedinfluenza virus with pneumonia

Interventions

Intervention1: Aragwadhadi kwath mentioned in bhavprakash jwarachikitsa 1/155: 80 ml lukewarm decoction of cassia fistula (fruit pulp), piper longum (root), cyperus rotundus (tubers), terminalia chebu

Sponsors

VaidhyaTushar Trivedi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Male or non-pregnant females aged >= 18 years with mild COVID-19 disease based on positive RT- PCR test. 2 Voluntary willingness of patient to give written informed consent prior to participation in trial.

Exclusion criteria

Exclusion criteria: 1 Pregnant lady or Lactating mother 2 History of known hypersensitivity to study drugs 3 Corona positive patient with severe diarrhoea or Vomiting 4 Known case of Diabetes Mellitus 5 Participating in any other clinical trial or Receiving any other medicines of alternative system

Design outcomes

Primary

MeasureTime frame
Proportion of Clinically and Virologically cured patientsTimepoint: at Day 5, 10 and 14

Secondary

MeasureTime frame
Adverse effectsTimepoint: any;Change in RNA levels (Ct values) of SARS-CoV-2 from RT-PCRTimepoint: day 5, 10 and 14;Hospital stay durationTimepoint: any;Proportion of patients turned into severe category of diseaseTimepoint: At the end of study

Countries

India

Contacts

Public ContactVaidhya Tushar Trivedi

Sanjivani Ayucare

vdtushartrivedi@gmail.com9426989485

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026